Literature DB >> 6265297

T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5.

W Gliński, S Obałek, S Jabłońska, G Orth.   

Abstract

Most of the patients with epidermodysplasia verruciformis (EV) were anergic to sensitization to dinitrochlorobenzene (DNCB) and were shown to have a decreased number of T lymphocytes and reduced lymphocyte PHA responsiveness. Preserved cell-mediated immunity (CMI) was found only in the abortive cases of EV infected with human papillomavirus type 3 (HPV-3). CMI was impaired to the same extent in patients with EV induced by HPV-3 and HPV-5, and in EV cases with combined infection with both viruses. In contrast to this, malignant transformation, i.e. of Bowen's carcinoma type, was observed only in the 7 patients infected with HPV-5. This could indicate that malignancy in EV is related rather to the oncogenic potential of HPV-5 type than to the extent of T cell defect that was similar in both EV varieties due to HPV-3 and HPV-5.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265297     DOI: 10.1159/000250262

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  11 in total

Review 1.  Immunopathology of papillomavirus-induced tumors in different tissues.

Authors:  S Jablonska; G Orth; M A Lutzner
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix.

Authors:  M Väyrynen; K Syrjänen; R Mäntyjärvi; O Castrén; S Saarikoski
Journal:  Genitourin Med       Date:  1985-06

3.  Papillomavirus DNA in warts of immunosuppressed renal allograft recipients.

Authors:  A Gassenmaier; P Fuchs; H Schell; H Pfister
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

4.  Generation of cell-mediated cytotoxicity against bovine-papilloma-virus-transformed primary mouse cell lines.

Authors:  A Laatikainen; H Karjalainen; H Sarkkinen; K Syrjänen; R Mäntyjärvi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 5.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

6.  EVER2 deficiency is associated with mild T-cell abnormalities.

Authors:  Amandine Crequer; Capucine Picard; Vincent Pedergnana; Annick Lim; Shen-Ying Zhang; Laurent Abel; Slawomir Majewski; Jean-Laurent Casanova; Stefania Jablonska; Gerard Orth; Emmanuelle Jouanguy
Journal:  J Clin Immunol       Date:  2012-08-19       Impact factor: 8.317

7.  Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid.

Authors:  A L Claudy; J L Touraine; D Mitanne
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 8.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

9.  The relation between the type of immunoreactive cells found in human papillomavirus (HPV) lesions of the uterine cervix and the subsequent behaviour of these lesions.

Authors:  K Syrjänen; M Väyrynen; O Castrén; R Mäntyjärvi; M Yliskoski
Journal:  Arch Gynecol       Date:  1984

10.  The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.

Authors:  Jaime S Horton; Alexander J Stokes
Journal:  Oncoimmunology       Date:  2014-04-15       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.